HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Pancreatic Cancer.
10 years of University of Kentucky’s Healthy Hearts for Women takes aim at heart disease
The University of Kentucky will mark a decade of raising awareness and continuing its effort to warn women about the dangers of heart disease with